GlaxoSmithKline PLC is a pharmaceutical giant that operates on a global scale. The company has already released research and medications that saved millions of lives. Explore the global leaders of ...

London: GSK plc has announced that the European Medicines Agency (EMA) has accepted the company's regulatory application to ...

This method should give us information to assess how appropriately the company pays the CEO. At the time of writing, our data says that GlaxoSmithKline plc has a market cap of UK£70b, and ...

Our data suggests that insiders own under 1% of GlaxoSmithKline plc in their own names. As it is a large company, we'd only expect insiders to own a small percentage of it. But it's worth noting ...

This removed any intermediate doubt that weakening respiratory revenue would cause the company to drastically cut its dividend. Also, considering its 9.3 billion transaction gain, GlaxoSmithKline ...

Glaxosmithkline Plc has filed a 13D form with the SEC disclosing ownership of 39,660,487 shares of 23andMe Holding Co. Class A (ME). This represents 13.2% of the company. 23andMe Holding Co., a ...

We can't gloss over the fact that GlaxoSmithKline faces challenges. Sales for the biggest revenue-generating drug in the company's lineup, Seretide/Advair, fell 16% year over year in the first ...

GlaxoSmithKline PLCGSK-0.10%decrease; red down pointing triangle on Monday said it would buy cancer-focused drug company Tesaro Inc. for about $4.16 billion, positioning the health-care giant in a ...

GlaxoSmithKline, the pharmaceutical company, said on Wednesday that it had fired Dr. Slaoui from his position as chairman of Galvani Bioelectronics. La revisión positiva probablemente asegure que ...

China has granted a green light for Glaxosmithkline plc’s human papillomavirus (HPV ... imported two-dose HPV vaccine for the age group to be approved in China, the company said. A three-dose schedule ...

News about GlaxoSmithKline PLC., including commentary and archival articles published in The New York Times.